spongistatins

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug Namespongistatins
Drug Alias NameSpongistatin 9spongistatin 2spongistatin 5Spongistatin 7spongistatin 1 +[9] 
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasmsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArizona State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb CelltechExeter UniversityAnticancer Inc +[5] 
Active IndicationsN/A
Inactive IndicationsNeoplasmsMycoses

Other Information

ATC CodeN/A
Related LinksN/A